Cargando…

Prognostic Value of MTV and TLG of (18)F-FDG PET in Patients with Stage I and II Non-Small-Cell Lung Cancer: a Meta-Analysis

PURPOSE: The present systematic literature review and meta-analysis focused on examining the significance of total lesion glycolysis (TLG) and metabolic tumor volume (MTV) in predicting the prognosis of stages I/II non-small-cell lung cancer (NSCLC) based on (18)F-FDG PET parameters. METHODS: Electr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wen, Weibo, Piao, Yongnan, Xu, Dongyuan, Li, Xiangdan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629622/ https://www.ncbi.nlm.nih.gov/pubmed/34887713 http://dx.doi.org/10.1155/2021/7528971

Ejemplares similares

Prognostic value of MTV and TLG of 18 F-FDG PET in patients with head and neck squamous cell carcinoma: A meta-analysis
por: Jin, Aihua, et al.
Publicado: (2022)

Prognostic value of maximum standard uptake value, metabolic tumour volume, and total lesion glycolysis of 18F-FDG PET/CT in patients with malignant pleural mesothelioma: a systematic review and meta-analysis
por: Wen, Weibo, et al.
Publicado: (2022)

Correlation of (18)F-FDG/PET SUV(max), SUV(mean), MTV, and TLG with HIF-1α in Patients with Colorectal Cancer
por: Kaymak, Zümrüt Arda, et al.
Publicado: (2021)

Prognostic value of baseline [(18)F]-fluorodeoxyglucose positron emission tomography parameters MTV, TLG and asphericity in an international multicenter cohort of nasopharyngeal carcinoma patients
por: Zschaeck, Sebastian, et al.
Publicado: (2020)

The reproducibility of MTV and TLG of soft tissue tumors calculated by FDG-PET: Comparison between the lower limit by the fixed value SUV 2.5 and that value by 30% of SUVmax
por: Iwasa, Hitomi, et al.
Publicado: (2023)

Prognostic Impact of Total Lesion Glycolysis (TLG) from Preoperative (18)F-FDG PET/CT in Stage II/III Colorectal Adenocarcinoma: Extending the Value of PET/CT for Resectable Disease
por: Lee, Sea-Won, et al.
Publicado: (2022)

Prognostic Value of Pretherapeutic Primary Tumor MTV from [(18)F]FDG PET in Radically Treated Cervical Cancer Patients
por: Cegla, Paulina, et al.
Publicado: (2021)

Prognostic value of the baseline 18F-FDG PET/CT metabolic tumour volume (MTV) and further stratification in low-intermediate (L-I) and high-intermediate (H-I) risk NCCNIPI subgroup by MTV in DLBCL MTV predict prognosis in DLBCL
por: Zhao, Peng, et al.
Publicado: (2020)

Prognostic value of maximum standard uptake value, metabolic tumor volume, and total lesion glycolysis of (18)F-FDG PET/CT in patients with renal carcinoma: A protocol for systematic review and meta analysis
por: Xuan, Dongchun, et al.
Publicado: (2020)

P034: Correlation between MTV, TLG and Serum TARC Concentration in Classical Hodgkin Lymphoma during First-Line Treatment
por: Romano, Ilaria, et al.
Publicado: (2022)

Prognostic value of combined MTV and ADC derived from baseline FDG PET/MRI in aggressive non-Hodgkins lymphoma
por: Husby, Trine, et al.
Publicado: (2022)

Prognostic value of lymphovascular space invasion in stage IA to IIB cervical cancer: A meta-analysis
por: Huang, Yuan, et al.
Publicado: (2023)

Prognostic value of (18)F-FDG PET in uterine cervical cancer patients with stage IIICr allocated by imaging
por: Isaji, Yuzu, et al.
Publicado: (2023)

Diagnostic value of [(18)F]FDG PET/MRI for staging in patients with ovarian cancer
por: Tsuyoshi, Hideaki, et al.
Publicado: (2020)

Diagnostic value of (18)F-FDG PET/MRI for staging in patients with endometrial cancer
por: Tsuyoshi, Hideaki, et al.
Publicado: (2020)

Systeme mtv programme mtv - survey
por: Sigaud, E
Publicado: (1991)

Prognostic value of pretreatment (18)F-FDG PET-CT for nasopharyngeal carcinoma patients
por: Huang, Yecai, et al.
Publicado: (2017)

The Prognostic Value of (18)F-FDG PET/CT and KRAS Mutation in Colorectal Cancers
por: Arslan, Esra, et al.
Publicado: (2020)

Prognostic values of ALDOB expression and (18)F-FDG PET/CT in hepatocellular carcinoma
por: Jia, Wenzhi, et al.
Publicado: (2022)

The Prognostic and Diagnostic Value of [(18)F]FDG PET/CT in Untreated Laryngeal Carcinoma
por: Al-Ibraheem, Akram, et al.
Publicado: (2023)

The role of metabolic tumor volume (MTV) measured by [18F] FDG PET/CT in predicting EGFR gene mutation status in non-small cell lung cancer
por: Liu, Ao, et al.
Publicado: (2017)

Prognostic value of metabolic variables of [18F]FDG PET/CT in surgically resected stage I lung adenocarcinoma
por: Wang, Xiao-Yi, et al.
Publicado: (2017)

The Prognostic Value of (18)F-FDG PET Imaging at Staging in Patients with Malignant Pleural Mesothelioma: A Literature Review
por: Taralli, Silvia, et al.
Publicado: (2021)

(18)F-FDG PET-CT for Staging of Conjunctival Melanoma
por: Damian, Andres, et al.
Publicado: (2013)

Prognostic value of lymph node ratio in cervical cancer: A meta-analysis
por: Cui, Haixia, et al.
Publicado: (2022)

Diagnostic value of integrated (18)F-FDG PET/MRI for staging of endometrial carcinoma: comparison with PET/CT
por: Yu, Yang, et al.
Publicado: (2022)

Prognostic Value of (18)F-FDG PET-CT in Nasopharyngeal Carcinoma: Is Dynamic Scanning Helpful?
por: Huang, Bingsheng, et al.
Publicado: (2015)

Prognostic value of pretreatment (18)F-FDG PET-CT in radiotherapy for patients with hepatocellular carcinoma
por: Jo, In Young, et al.
Publicado: (2015)

Prognostic values of mid-radiotherapy (18)F-FDG PET/CT in patients with esophageal cancer
por: Kim, Nalee, et al.
Publicado: (2019)

Prognostic Values of Baseline (18)F-FDG PET/CT in Patients with Peripheral T-Cell Lymphoma
por: Zhou, Yeye, et al.
Publicado: (2020)

Diagnostic and prognostic value of F-18 FDG PET/CT in patients with carcinoma of unknown primary
por: Bicakci, Nilufer
Publicado: (2022)

The Potential Prognostic Value of Dual-Imaging PET Parameters Based on (18)F-FDG and (18)F-OC for Neuroendocrine Neoplasms
por: Hou, Jiale, et al.
Publicado: (2022)

Prognostic Value of (18)F-FDG PET/CT Metabolic Parameters in Surgically Treated Stage I Lung Adenocarcinoma Patients
por: Tosi, Davide, et al.
Publicado: (2021)

Prognostic value of the metabolic score obtained via [(18)F]FDG PET/CT and a new prognostic staging system for gastric cancer
por: Kim, Sung Hoon, et al.
Publicado: (2022)

Prognostic Value of (18)F-FDG PET/CT Volume-Based Metabolic Parameters in Patients with Node-Negative Stage II Esophageal Squamous Cell Carcinoma
por: Shen, Daniel Hueng-Yuan, et al.
Publicado: (2021)

Diagnostic performance of prospective same-day 18F-FDG PET/MRI and 18F-FDG PET/CT in the staging and response assessment of lymphoma
por: Mistry, Vijay, et al.
Publicado: (2023)

Diagnostic Value of (18)F-FDG-PET/CT in Patients with FUO
por: Georga, Stamata, et al.
Publicado: (2020)

Prognostic impact of (18)F-FDG PET/CT in pathologic stage II invasive ductal carcinoma of the breast: re-illuminating the value of PET/CT in intermediate-risk breast cancer
por: Park, Hye Lim, et al.
Publicado: (2023)

Added value of quantitative, multiparametric 18F-FDG PET/MRI in the locoregional staging of rectal cancer
por: Herold, Alexander, et al.
Publicado: (2022)

The Prognostic Value of (18)F-FDG PET/CT for Hepatocellular Carcinoma Treated with Transarterial Chemoembolization (TACE)
por: Ma, Wenhui, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_gp916r10i201pg3kguvjiqk6fj